Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · IEX Real-Time Price · USD
3.100
-0.150 (-4.62%)
Jul 2, 2024, 4:30 PM EDT - Market closed

Akari Therapeutics, Statistics

Total Valuation

AKTX has a market cap or net worth of $21.56 million. The enterprise value is $20.25 million.

Market Cap 21.56M
Enterprise Value 20.25M

Important Dates

The last earnings date was Thursday, May 16, 2024, before market open.

Earnings Date May 16, 2024
Ex-Dividend Date n/a

Share Statistics

AKTX has 6.96 million shares outstanding.

Shares Outstanding 6.96M
Owned by Insiders (%) 38.21%
Owned by Institutions (%) 1.51%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.44

Current Ratio 0.44
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count 9
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -6.40% in the last 52 weeks. The beta is 0.85, so AKTX's price volatility has been lower than the market average.

Beta (5Y) 0.85
52-Week Price Change -6.40%
50-Day Moving Average 2.06
200-Day Moving Average 2.60
Relative Strength Index (RSI) 58.36
Average Volume (20 Days) 36,061

Short Selling Information

Short Interest 15,745
Short Previous Month 21,616
Short % of Shares Out 0.17%
Short % of Float n/a
Short Ratio (days to cover) 0.57

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income n/a
Pretax Income n/a
Net Income n/a
EBITDA n/a
EBIT n/a
Earnings Per Share (EPS) -$3.14
Full Income Statement

Balance Sheet

The company has $1.31 million in cash and no debt, giving a net cash position of $1.31 million or $0.19 per share.

Cash & Cash Equivalents 1.31M
Total Debt n/a
Net Cash 1.31M
Net Cash Per Share $0.19
Equity (Book Value) -3.55M
Book Value Per Share -0.51
Working Capital -3.55M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

AKTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -115.48%
Shareholder Yield -115.48%
Earnings Yield n/a
FCF Yield n/a

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on August 17, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date Aug 17, 2023
Split Type Reverse
Split Ratio 1:20

Scores

Altman Z-Score n/a
Piotroski F-Score n/a